Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-26
2005-04-26
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S306000, C546S138000, C546S183000
Reexamination Certificate
active
06884806
ABSTRACT:
The present application describes novel bicyclic lactam derivatives of formula I:or pharmaceutically acceptable salt forms thereof, wherein A, B, C, D, R1, and R2are defined in the present specification, which are useful as metalloprotease, TNF-α, and/or aggrecanase inhibitors.
REFERENCES:
patent: 4851423 (1989-07-01), Girijavallabhan et al.
patent: 5508272 (1996-04-01), Robl
patent: 5889042 (1999-03-01), MacLean et al.
patent: 6107331 (2000-08-01), MacLean et al.
patent: 6159987 (2000-12-01), Yamamoto et al.
patent: 6262065 (2001-07-01), Pearson et al.
patent: 796245 (1997-09-01), None
patent: WO 9100858 (1991-01-01), None
patent: WO 9621656 (1996-07-01), None
patent: WO 9805333 (1998-02-01), None
Lebl et al. Peptides: The Wave of the Future, Proceedings of the second International and Seventeenth American Peptide Symposium, San Diego, Jun. 9-14, 597-598, 2001. CA 138: 338452.
Decicco Carl P.
Duan Jingwu
Song Ying
Voss Matthew E.
Balasubramanian Venkataraman
Bristol--Myers Squibb Company
Sun Jing G.
Vand David H.
LandOfFree
Bicyclic lactam derivatives as inhibitors of matrix... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic lactam derivatives as inhibitors of matrix..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic lactam derivatives as inhibitors of matrix... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3373832